Log in

NASDAQ:INMBINmune Bio News Headlines

$3.64
+0.28 (+8.33 %)
(As of 04/10/2020 02:53 AM ET)
Add
Compare
Today's Range
$3.47
Now: $3.64
$3.79
50-Day Range
$2.21
MA: $3.67
$5.29
52-Week Range
$2.20
Now: $3.64
$11.50
Volume12,923 shs
Average Volume30,387 shs
Market Capitalization$39.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54

Headlines

INmune Bio (NASDAQ INMB) News Headlines

Source:
DateHeadline
INmune Bio (INMB) vs. Its Peers Financial AnalysisINmune Bio (INMB) vs. Its Peers Financial Analysis
www.americanbankingnews.com - April 7 at 7:24 PM
Financial Contrast: INmune Bio (INMB) & The CompetitionFinancial Contrast: INmune Bio (INMB) & The Competition
www.americanbankingnews.com - April 7 at 1:40 PM
Reviewing INmune Bio (INMB) and Its PeersReviewing INmune Bio (INMB) and Its Peers
www.americanbankingnews.com - April 7 at 9:23 AM
INmune Bio Inc (NASDAQ:INMB) Expected to Announce Earnings of -$0.21 Per ShareINmune Bio Inc (NASDAQ:INMB) Expected to Announce Earnings of -$0.21 Per Share
www.americanbankingnews.com - March 30 at 8:28 AM
INmune Bio (INMB) and Its Rivals Head-To-Head SurveyINmune Bio (INMB) and Its Rivals Head-To-Head Survey
www.americanbankingnews.com - March 29 at 1:44 AM
INmune Bio Inc (NASDAQ:INMB) Sees Large Drop in Short InterestINmune Bio Inc (NASDAQ:INMB) Sees Large Drop in Short Interest
www.americanbankingnews.com - March 26 at 11:16 PM
Analyzing INmune Bio (INMB) and Its RivalsAnalyzing INmune Bio (INMB) and Its Rivals
www.americanbankingnews.com - March 24 at 6:17 PM
Head-To-Head Survey: INmune Bio (INMB) versus Its CompetitorsHead-To-Head Survey: INmune Bio (INMB) versus Its Competitors
www.americanbankingnews.com - March 24 at 4:41 PM
INmune Bio (INMB) and Its Rivals Head to Head ContrastINmune Bio (INMB) and Its Rivals Head to Head Contrast
www.americanbankingnews.com - March 23 at 10:53 AM
Critical Review: INmune Bio (INMB) and Its PeersCritical Review: INmune Bio (INMB) and Its Peers
www.americanbankingnews.com - March 23 at 8:19 AM
INmune Bio (INMB) versus Its Competitors Financial AnalysisINmune Bio (INMB) versus Its Competitors Financial Analysis
www.americanbankingnews.com - March 22 at 2:06 AM
Financial Survey: INmune Bio (INMB) vs. The CompetitionFinancial Survey: INmune Bio (INMB) vs. The Competition
www.americanbankingnews.com - March 22 at 12:10 AM
INmune Bio Inc (NASDAQ:INMB) Forecasted to Post Q1 2020 Earnings of ($0.14) Per ShareINmune Bio Inc (NASDAQ:INMB) Forecasted to Post Q1 2020 Earnings of ($0.14) Per Share
www.americanbankingnews.com - March 18 at 8:34 AM
INmune Bio (INMB) & Its Competitors Head-To-Head SurveyINmune Bio (INMB) & Its Competitors Head-To-Head Survey
www.americanbankingnews.com - March 17 at 2:21 PM
INmune Bio Inc (NASDAQ:INMB) to Post Q4 2020 Earnings of ($0.23) Per Share, Zacks Investment Research ForecastsINmune Bio Inc (NASDAQ:INMB) to Post Q4 2020 Earnings of ($0.23) Per Share, Zacks Investment Research Forecasts
www.americanbankingnews.com - March 17 at 7:55 AM
Financial Comparison: INmune Bio (INMB) versus Its CompetitorsFinancial Comparison: INmune Bio (INMB) versus Its Competitors
www.americanbankingnews.com - March 16 at 8:22 PM
INMB: Multiple Milestones Ahead in 2020…INMB: Multiple Milestones Ahead in 2020…
finance.yahoo.com - March 16 at 12:09 PM
INmune Bio, Inc. Reports Fourth Quarter and Full Year 2019 Results - Drug Pipeline Expands to Now Include Cancer, Alzheimer’s Disease and NASHINmune Bio, Inc. Reports Fourth Quarter and Full Year 2019 Results - Drug Pipeline Expands to Now Include Cancer, Alzheimer’s Disease and NASH
finance.yahoo.com - March 11 at 1:41 PM
INmune Bio, Inc. to Present at the 32nd Annual ROTH Conference on March 17INmune Bio, Inc. to Present at the 32nd Annual ROTH Conference on March 17
finance.yahoo.com - March 5 at 1:45 PM
INmune Bio, Inc. Schedules Conference Call to Report 2019 Fourth Quarter and Full Year Financial ResultsINmune Bio, Inc. Schedules Conference Call to Report 2019 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - February 27 at 1:21 PM
INmune Bio, Inc. Awarded $500,000 Grant for Development of Novel Treatment to Reprogram Innate Immune System in People Living with ALSINmune Bio, Inc. Awarded $500,000 Grant for Development of Novel Treatment to Reprogram Innate Immune System in People Living with ALS
finance.yahoo.com - February 10 at 3:11 PM
Have Insiders Been Buying INmune Bio Inc. (NASDAQ:INMB) Shares?Have Insiders Been Buying INmune Bio Inc. (NASDAQ:INMB) Shares?
finance.yahoo.com - January 29 at 2:54 PM
INmune Bio up 4% on potential of lead candidate in AlzheimersINmune Bio up 4% on potential of lead candidate in Alzheimer's
seekingalpha.com - January 2 at 4:10 PM
INmune Bio, Inc. Announces Data on its Lead Compound Which Highlights The Potential to Lower The Risk of Alzheimers Disease in Obese IndividualsINmune Bio, Inc. Announces Data on its Lead Compound Which Highlights The Potential to Lower The Risk of Alzheimer's Disease in Obese Individuals
finance.yahoo.com - January 2 at 4:10 PM
INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II TrialsINmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials
finance.yahoo.com - December 17 at 1:36 PM
INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 StudyINmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study
finance.yahoo.com - December 2 at 1:36 PM
INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference WebinarINmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar
finance.yahoo.com - November 26 at 8:05 AM
INmune Bio Inc. to Discuss Potential New Alzheimers Disease Treatments in CTAD Pre-Conference WebinarINmune Bio Inc. to Discuss Potential New Alzheimer's Disease Treatments in CTAD Pre-Conference Webinar
feeds.benzinga.com - November 26 at 6:40 AM
INMB: Potential Link Between Obesity and Neuroinflammation Shown in Mouse Model of Alzheimer’s…INMB: Potential Link Between Obesity and Neuroinflammation Shown in Mouse Model of Alzheimer’s…
finance.yahoo.com - November 25 at 3:09 PM
INmune Bio, Inc. Strengthens Board of Directors with Appointment of Veteran Finance Executive Marcia AllenINmune Bio, Inc. Strengthens Board of Directors with Appointment of Veteran Finance Executive Marcia Allen
finance.yahoo.com - November 19 at 1:52 PM
INmune Bio EPS misses by $0.09INmune Bio EPS misses by $0.09
seekingalpha.com - November 8 at 8:32 PM
INmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder UpdateINmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder Update
finance.yahoo.com - November 8 at 8:32 PM
Heres Why Were Not Too Worried About INmune Bios (NASDAQ:INMB) Cash Burn SituationHere's Why We're Not Too Worried About INmune Bio's (NASDAQ:INMB) Cash Burn Situation
finance.yahoo.com - October 21 at 5:57 PM
INmune Bio, Inc. Announces Potentially Strong Link Between Obesity and Alzheimers Disease at the Society for Neuroscience 49th Annual MeetingINmune Bio, Inc. Announces Potentially Strong Link Between Obesity and Alzheimer's Disease at the Society for Neuroscience 49th Annual Meeting
finance.yahoo.com - October 21 at 5:57 PM
Here's Why We're Not Too Worried About INmune Bio's (NASDAQ:INMB) Cash Burn SituationHere's Why We're Not Too Worried About INmune Bio's (NASDAQ:INMB) Cash Burn Situation
finance.yahoo.com - October 21 at 12:56 PM
INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual MeetingINmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting
finance.yahoo.com - October 17 at 1:00 PM
INmune Bio Inc. to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in OctoberINmune Bio Inc. to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
finance.yahoo.com - October 8 at 1:12 PM
CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq’s MarketSite and Announces Presentation at World Immunotherapy CongressCEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq’s MarketSite and Announces Presentation at World Immunotherapy Congress
finance.yahoo.com - September 24 at 12:32 PM
INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite SymposiumINmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium
finance.yahoo.com - September 23 at 1:16 PM
INmune Bio Invited to Speak on Company’s Advancements in Cancer Treatments at the Targeting Innate Immunity Congress and MarketsandMarkets Next Gen Immuno-Oncology CongressINmune Bio Invited to Speak on Company’s Advancements in Cancer Treatments at the Targeting Innate Immunity Congress and MarketsandMarkets Next Gen Immuno-Oncology Congress
finance.yahoo.com - September 17 at 8:30 PM
INmune Bio nabs new patent in U.S.INmune Bio nabs new patent in U.S.
seekingalpha.com - September 12 at 11:55 AM
INmune Bio Inc. Announces USPTO Allowance of Key Patent Covering Its DN-TNFa Platform Technology for Treating CancerINmune Bio Inc. Announces USPTO Allowance of Key Patent Covering Its DN-TNFa Platform Technology for Treating Cancer
finance.yahoo.com - September 12 at 11:55 AM
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment ConferenceINmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 6 at 3:54 PM
5 Hot Insider Trading Stocks to Buy Under $105 Hot Insider Trading Stocks to Buy Under $10
investorplace.com - September 4 at 3:32 PM
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment ConferenceINmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
www.globenewswire.com - September 4 at 9:08 AM
Read This Before Selling INmune Bio Inc. (NASDAQ:INMB) SharesRead This Before Selling INmune Bio Inc. (NASDAQ:INMB) Shares
finance.yahoo.com - August 21 at 3:41 PM
INMB: Positive Preliminary Phase 1 Data for INB03…INMB: Positive Preliminary Phase 1 Data for INB03…
finance.yahoo.com - August 21 at 11:14 AM
INmune Bio Inc. (INMB) Second Quarter 2019 Financial Results and Shareholder Update - SlideshowINmune Bio Inc. (INMB) Second Quarter 2019 Financial Results and Shareholder Update - Slideshow
seekingalpha.com - August 20 at 10:45 AM
INmune Bio EPS beats by $0.17INmune Bio EPS beats by $0.17
seekingalpha.com - August 12 at 1:03 PM
INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder UpdateINmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
finance.yahoo.com - August 12 at 1:03 PM
This page was last updated on 4/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel